Bicara Therapeutics Inc. · NASDAQ:BCAX
Hyep Ivan sold 28,000 Bicara Therapeutics Inc. shares (Form 4)
Traded Jul 8, 2026 · Filed Jul 10, 2026
On Jul 8, 2026, Hyep Ivan (Chief Financial Officer) sold 28,000 Bicara Therapeutics Inc. shares at an average US$28.84 for US$808K under a trading plan, leaving 129,855 shares. Filed Jul 10, 2026 (Form 4).
- Sold
- 28,000 shares
- Price
- US$28.84 average (US$28.60 to US$30.31)
- Value
- US$808K
- Holding after
- 129,855 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | Option exercise | 12,500 | US$3.79 | 157,855 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 22,757 | US$28.60 | 135,098 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 4,413 | US$29.82 | 130,685 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 830 | US$30.31 | 129,855 | Direct |
Source
Related
- Bicara Therapeutics Inc.
- Hyep Ivan
- Bicara Therapeutics Inc. shareholders
- Form 4 · Hyep Ivan · Aug 12, 2026
- Form 4 · Hyep Ivan · May 26, 2026
- Form 4 · Hyep Ivan · Apr 22, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Mazumdar Claire · Aug 12, 2026
- Form 4 · Cohlhepp Ryan · Aug 12, 2026